Physician-Led Care You will meet with a licensed physician or nurse practitioner who reviews your health history, symptoms, goals, and lab results before building your treatment plan
Weight loss statistics: The website presents several figures, including "6x more weight loss than exercise and diet alone," "lose an average of 18% of your body weight," and "93% kept the weight off for good." According to fine print on the website, these figures are described as being based on "MEDVi patients over their first 6 months of treatment." The company's own disclosures state that "all claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals." The disclosures further state that "results from compounded medications found on the MEDVi platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations." Customer testimonials: The MEDVi website includes named customer testimonials with specific weight loss figures and outcomes attributed to verified customers
GLP-1 receptor activation is associated with reduced appetite and slowed gastric emptying
The HCG Institute offers a 30-day supply of glutamic acid troches
The edges of the patches can look smooth or irregular and may show redness or brownish discoloration
In 2021, Semaglutide and Tirzepatide were FDA-approved to help with weight loss with the injectable treatment known under the brand names WeGovy and Mounjaro
